Intracellular calcium flux assays are essential tools for monitoring signal transduction pathways and conducting high-throughput screening of G protein-coupled receptors (GPCRs) and calcium channel targets. Since the introduction of Fluo-3 in 1989, successive generations of calcium indicators—including Fluo-4, Fluo-8, and Cal-520—have delivered progressively improved signal-to-background ratios, establishing themselves as standard indicators for confocal microscopy, flow cytometry, and high-throughput screening applications. Despite its widespread adoption, Fluo-4 presents significant limitations. Most notably, intracellular calcium assays using Fluo-4 AM require probenecid to prevent the dye from leaking out of cells—a requirement shared with its predecessor, Fluo-3. This dependency on probenecid compromises assay reliability, as probenecid exhibits well-documented, complex cellular effects that can confound results.

Calbryte™ 520 AM represents a next-generation solution to these challenges. This novel, cell-permeable calcium indicator enters cells in a non-fluorescent, inactive form. Once inside, intracellular esterases cleave the AM ester, activating the indicator and rendering it calcium-responsive. The hydrolyzed product becomes a polar molecule that cannot cross cell membranes, effectively trapping it within the cell—eliminating the need for probenecid. When bound to calcium ions, Calbryte™ 520 generates an exceptionally bright fluorescent signal with a superior signal-to-background ratio. Importantly, Calbryte™ 520 shares the same excitation and emission wavelengths as Fluo-4, allowing seamless integration into existing Fluo-4 assay protocols. The combination of enhanced signal quality, improved intracellular retention, and probenecid-free operation makes Calbryte™ 520 AM the most robust calcium indicator available for evaluating GPCR and calcium channel targets, as well as screening their agonists and antagonists in living cells.